PDI Reports 2009 Third Quarter Financi...(strategic initiatives relating to levera...),Health

Date:11/5/2009

strategic initiatives relating to leveraging and expanding its core CSO capabilities, expanding its range of integrated, value-added services and reducing expenses, adverse changes in outsourcing trends in the pharmaceutical industry or a reduction or elimination of the role of pharmaceutical sales representatives. Also, with respect to statements regarding anticipated future savings relating to the impending relocation of our corporate headquarters, these savings may be offset in whole or in part by expenses associated with the lease for our current corporate headquarters unless we are able to successfully sublet this facility in a timely manner. Additionally, all forward-looking statements are subject to the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2008, and PDI's subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

                                  PDI, INC.
         CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
                  (in thousands, except for per share data)

                                      Three Months        Nine Months
                                          Ended              Ended
                                      September 30,      September 30,
                                      -------------      -------------
                                      2009     2008      2009      2008
                                      ----     ----      ----      ----

    
'/>"/>
SOURCE  PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 
Related medicine technology :

1. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
2. Symmetry Medical Reports Third Quarter 2009 Financial Results
3. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
4. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
5. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
6. HeartWare International Reports Third Quarter Revenues of $7.5 Million
7. Varian, Inc. Reports Fourth Quarter 2009 Results
8. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
9. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
10. Cambrex Reports Third Quarter 2009 Results
11. Regeneron Reports Third Quarter 2009 Financial and Operating Results